{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:44:22Z","timestamp":1790315062558,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T00:00:00Z","timestamp":1362182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1245\/s10434-012-2845-x","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T19:39:22Z","timestamp":1362253162000},"page":"1093-1100","source":"Crossref","is-referenced-by-count":78,"title":["The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"20","author":[{"given":"Marcello","family":"Deraco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Baratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionut","family":"Hutanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Bertuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,2]]},"reference":[{"key":"2845_CR1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","volume":"79","author":"J Peto","year":"1999","unstructured":"Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer. 1999;79:666\u201372.","journal-title":"Br J Cancer."},{"key":"2845_CR2","volume-title":"Cancer: Principles and Practice of Oncology","author":"V DeVita","year":"2004","unstructured":"DeVita V, Hellman S, Rosenberg S. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia: Lippincott Williams &Wilkins; 2004.","edition":"7"},{"key":"2845_CR3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/000313480106701019","volume":"67","author":"BW Loggie","year":"2001","unstructured":"Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR, Levine EA. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg. 2001;67:999\u20131003.","journal-title":"Am Surg."},{"key":"2845_CR4","doi-asserted-by":"crossref","unstructured":"Garcia Carbonero R, Paz-Ares L. Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol. 2006;32:676\u201381.","DOI":"10.1016\/j.ejso.2006.03.009"},{"key":"2845_CR5","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636\u201344.","journal-title":"J Clin Oncol."},{"key":"2845_CR6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","volume":"7","author":"PA Janne","year":"2005","unstructured":"Janne PA, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, et al. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer. 2005;7:40\u20136.","journal-title":"Clin Lung Cancer."},{"key":"2845_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","volume":"64","author":"G Carteni","year":"2009","unstructured":"Carteni G, Manegold C, Garcia GM, Siena S, Zielinski CC, Amadori D. Malignant peritoneal mesothelioma-results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent. Lung Cancer. 2009;64:211\u20138.","journal-title":"Lung Cancer."},{"key":"2845_CR8","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","volume":"26","author":"GR Simon","year":"2008","unstructured":"Simon GR, Verschraegen CF, J\u00e4nne PA, Langer CJ, Dowlati A, Gadgeel SM, et al. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol. 2008;26:3567\u201372.","journal-title":"J Clin Oncol."},{"key":"2845_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jso.21388","volume":"100","author":"M Deraco","year":"2009","unstructured":"Deraco M, Baratti D, Kusamura S, Laterza B, Balestra MR. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol. 2009;100:321\u20138.","journal-title":"J Surg Oncol."},{"key":"2845_CR10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1245\/s10434-007-9691-2","volume":"15","author":"D Baratti","year":"2008","unstructured":"Baratti D, Kusamura S, Nonaka D, Langer M, Langer M, Andreola S, Favaro M, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15:526\u201334.","journal-title":"Ann Surg Oncol."},{"key":"2845_CR11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cncr.10176","volume":"94","author":"CR Rossi","year":"2002","unstructured":"Rossi CR, Foletto M, Mocellin S, Pilati P, Quintieri L, De Salvo GL, et al. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer. 2002;94:492\u20139.","journal-title":"Cancer."},{"key":"2845_CR12","first-page":"49","volume":"15","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49\u201358.","journal-title":"J Exp Clin Cancer Res."},{"key":"2845_CR13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jso.21057","volume":"98","author":"R Younan","year":"2008","unstructured":"Younan R, Kusamura S, Baratti D, Cloutier AS, Deraco M. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol. 2008;98:253\u20137.","journal-title":"J Surg Oncol."},{"key":"2845_CR14","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1245\/s10434-007-9429-1","volume":"14","author":"S Kusamura","year":"2007","unstructured":"Kusamura S, Baratti D, Younan R, Laterza B, Oliva GD, Costanzo P, et al. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol. 2007;14:2550\u20138.","journal-title":"Ann Surg Oncol."},{"key":"2845_CR15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373\u201383.","journal-title":"J Chron Dis."},{"key":"2845_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","volume":"6","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727\u201331.","journal-title":"Ann Surg Oncol."},{"key":"2845_CR17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/SLA.0b013e3182436c28","volume":"255","author":"S Kusamura","year":"2012","unstructured":"Kusamura S, Baratti D, Deraco M. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg. 2012;255:348\u201356.","journal-title":"Ann Surg."},{"key":"2845_CR18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bjc.6604522","volume":"99","author":"AL Farquharson","year":"2008","unstructured":"Farquharson AL, Pranesh N, Witham G, Swindell R, Taylor MB, Renehan AG, et al. A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Cancer. 2008;99:591\u20136.","journal-title":"Br J Cancer."},{"key":"2845_CR19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943\u201353.","journal-title":"N Engl J Med."},{"key":"2845_CR20","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.","journal-title":"J Clin Oncol."},{"key":"2845_CR21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366:610\u20138.","journal-title":"N Engl J Med."},{"key":"2845_CR22","doi-asserted-by":"crossref","unstructured":"De Pangher Manzini V, Brollo A, Bianchi C. Thrombocytosis in malignant pleural mesothelioma. Tumori. 1990;76:576\u20138.","DOI":"10.1177\/030089169007600613"},{"key":"2845_CR23","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.ejca.2010.06.130","volume":"46","author":"F Perrone","year":"2010","unstructured":"Perrone F, Jocoll\u00e8 G, Pennati M, Deraco M, Baratti D, Brich S, et al. Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma. Eur J Cancer. 2010;46:2837\u201348.","journal-title":"Eur J Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2845-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2845-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2845-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T20:14:23Z","timestamp":1715026463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2845-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,2]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2845"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2845-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,2]]}}}